Tech Company Financing Transactions
RVAC Medicines Funding Round
CBC Capital, Edbi and GS Holdings participated in a $140 million Series B funding round for RVAC Medicines. The round was announced on 4/26/2022.
Transaction Overview
Company Name
Announced On
4/26/2022
Transaction Type
Venture Equity
Amount
$140,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds from this financing round will be used for preclinical and clinical development of the company's vaccine and therapeutics programs and building world class R&D centers and manufacturing capabilities, including a new R&D center in Singapore and manufacturing facilities in both Singapore and China.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Unit 2601 & 2611-12, CITIC Square No.1168 West Nanjing Road,
Shanghai, 200041
China
Shanghai, 200041
China
Phone
Undisclosed
Website
Email Address
Overview
RVAC Medicines is an mRNA platform company. We are building a diverse pipeline of innovative medicines. Our leading asset, a COVID-19 vaccine, is quickly moving into clinical trials and is well-positioned to serve emerging markets in regions that are struggling with vaccine access, where we are rapidly establishing regional manufacture capabilities. Our company has built its team with top-tier scientists and established key partnerships to leverage clinically validated technologies. Incubated by the CBC Group, RVAC Medicines is headquartered in Singapore with R&D centers in Boston and Shanghai.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sean Fu
Chief Medical Officer
Roberto Guerciolini
Chief Scientific Officer
Jason Zhang
Browse more venture capital transactions:
Prev: 4/26/2022: Crafty venture capital transaction
Next: 4/26/2022: AI Medical Service venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs